Bernhard Lampert

First Pharmacokinetic and Safety Study in Humans of the Novel Lipid Antiviral Conjugate CMX001, a Broad-Spectrum Oral Drug Active against Double-Stranded DNA Viruses

Wendy Painter, Alice Robertson, Lawrence C. Trost et al. · Antimicrobial Agents and Chemotherapy · 2012 · 175 citations · Full text

Intraocular Pressure, Blood Chemistry, Neurovirology +14

Development of CMX001 for the Treatment of Poxvirus Infections

Randall Lanier, Lawrence C. Trost, Tim Tippin et al. · Viruses · 2010 · 159 citations · Full text

Phosphonic Acid, Pathogenesis, Viral Pathogenesis +11

Efficacy of therapeutic intervention with an oral ether–lipid analogue of cidofovir (CMX001) in a lethal mousepox model

Scott Parker, Erin Touchette, Christina Oberle et al. · Antiviral Research · 2007 · 102 citations · Full text

Lethal Mousepox Model, Medicine, Immunology +8

Evaluation of Hexadecyloxypropyl-9- <i>R</i> -[2-(Phosphonomethoxy)Propyl]- Adenine, CMX157, as a Potential Treatment for Human Immunodeficiency Virus Type 1 and Hepatitis B Virus Infections

George R. Painter, Merrick R. Almond, Lawrence C. Trost et al. · Antimicrobial Agents and Chemotherapy · 2007 · 72 citations · Full text

Rapid Enantiomeric Quantification of an Antiviral Nucleoside Agent (<scp>d</scp>,<scp>l</scp>-FMAU, 2‘-Fluoro-5-methyl-β,<scp>d</scp>,<scp>l</scp>-arabinofurano- syluracil) by Mass Spectrometry

W. Andy Tao, Lianming Wu, R. Graham Cooks et al. · Journal of Medicinal Chemistry · 2001 · 48 citations